Modulating sensorimotor gating in healthy volunteers: The effects of desipramine and haloperidol

Psychiatry Research

Volumn 127, Issue 3, 2004, Pages 195-205

  Oranje, Bob ^a,b,c   Kahn, René S ^b   Kemner, Chantal ^b   Verbaten, Marinus N ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Dopamine; Habituation; Noradrenaline; Prepulse inhibition; Schizophrenia

Indexed keywords

DESIPRAMINE; HALOPERIDOL; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HABITUATION; HEALTH STATUS; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MODULATION; NORADRENERGIC SYSTEM; NORMAL HUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; VOLUNTEER;

ADRENERGIC UPTAKE INHIBITORS; ADULT; ANTIPSYCHOTIC AGENTS; CROSS-OVER STUDIES; DESIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROMYOGRAPHY; HABITUATION, PSYCHOPHYSIOLOGIC; HALOPERIDOL; HEART RATE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; PSYCHOMOTOR PERFORMANCE; STARTLE REACTION; TIME FACTORS;

EID: 3543120110     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2004.04.002     Document Type: Article

References (56)

1. Abduljawad K.A., Langley R.W., Bradshaw C.M., Szabadi E. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. Journal of Psychopharmacology. 12:1998;239-245
2. Andreasen N.C., Flaum M., Arndt S. The comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing psychopathology and diagnosis. Archives of General Psychiatry. 49:1992;615-623
3. Anthony B.J. In the Blink of an Eye: Implications of Reflex Modification for Information Processing. Advances in Psychophysiology. 1985;167-218 JAI Press Inc, Greenwich, CT
4. Bakshi V.P., Geyer M.A. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122:1995;198-201
5. Bakshi V.P., Geyer M.A. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. Journal of Pharmacology and Experimental Therapeutics. 283:1997;666-674
6. Bakshi V.P., Geyer M.A. Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats. Neuroscience. 92:1999;113-121
7. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology. 156:2001;234-258
8. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry. 49:1992;206-215
9. Braff D.L., Stone C., Callaway E., Geyer M.A., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343
10. Braff D.L., Swerdlow N.R., Geyer M.A. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. American Journal of Psychiatry. 156:1999;596-602
11. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Archives of General Psychiatry. 47:1990;181-188
12. Caine S.B., Geyer M.A., Swerdlow N.R. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat. Neuropsychopharmacology. 12:1995;139-145
13. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. American Journal of Psychiatry. 148:1991;1474-1486
14. Dulawa S.C., Gross C., Stark K.L., Hen R., Geyer M.A. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology. 22:2000;650-659
15. Duncan G.E., Sheitman B.B., Lieberman J.A. An integrated view of pathophysiological models of schizophrenia. Brain Research: Brain Research Reviews. 29:1999;250-264
16. Fendt M. Enhancement of prepulse inhibition after blockade of GABA activity within the superior colliculus. Brain Research. 833:1999;81-85
17. Freedman R., Waldo M.C., Bickford-Wimer P.C., Nagamoto H. Elementary neuronal dysfunctions in schizophrenia. Schizophrenia Research. 4:1991;233-243
18. Geyer M.A., Braff D.L. Habituation of the blink reflex in normals and schizophrenic patients. Psychophysiology. 19:1982;1-6
19. Geyer M.A., Braff D.L. Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophrenia Bulletin. 13:1987;643-668
20. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology. 156:2001;117-154
21. st ed:1994;146-162 Blackwell Science Ltd, Oxford
22. Goodman-Gilman A., Hardman J.G., Limbird L.E. The Pharmacological Basis of Therapeutics. 10th ed:2001;McGraw-Hill, New York
23. Graham F.K. The more or less startling effects of weak prestimulation. Psychophysiology. 12:1975;238-248
24. Gresch P.J., Sved A.F., Zigmond M.J., Finlay J.M. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. Journal of Neurochemistry. 65:1995;111-116
25. Grillon C., Ameli R., Charney D.S., Krystal J.H., Braff D.L. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biological Psychiatry. 32:1992;939-943
26. Hazlett E.A., Buchsbaum M.S., Haznedar M.M., Singer M.B., Germans M.K., Schnur D.B., Jimenez E.A., Buchsbaum B.R., Troyer B.T. Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients. Psychophysiology. 35:1998;186-198
27. Kahn R.S., Davidson M. Dopamine in schizophrenia. den Boer J.A., Westenberg H.G.M., van Praag H.M. Advances in the Neurobiology of Schizophrenia. 1995;204-220 Wiley and Sons Ltd
28. Kandel E.R. Disorders of mood: depression, mania, and anxiety disorders. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neuroscience. 1991;869-886 Prentice Hall International, London
29. Kellogg C.K., Sullivan A.T., Bitran D., Ison J.R. Modulation of noise-potentiated acoustic startle via the benzodiazepine - gamma-aminobutyric acid receptor complex. Behavioral Neuroscience. 105:1991;640-646
30. Klarner A., Koch M., Schnitzler H.U. Induction of Fos-protein in the forebrain and disruption of sensorimotor gating following N-methyl-D-aspartate infusion into the ventral hippocampus of the rat. Neuroscience. 84:1998;443-452
31. Koch M. The neurobiology of startle. Progress in Neurobiology. 59:1999;107-128
32. Koch M., Schnitzler H.U. The acoustic startle response in rats - circuits mediating evocation, inhibition and potentiation. Behavioural Brain Research. 89:1997;35-49
33. th ed. J.A Barth, Leipzig
34. Kumari V., Mulligan O.F., Cotter P.A., Poon L., Toone B.K., Checkley S.A., Gray J.A. Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers. Behavioural Pharmacology. 9:1998;567-576
35. Lake C.R., Kleinman J.E., Kafka M.S., Ko G.N., Moore S.S., Ziegler M. Norepinephrine metabolism in schizophrenia. Henn F.A., DeLisi L.E. Neurochemistry and Neuropharmacology of Schizophrenia. 1987;227-256 Elsevier Science Publishing Co, Amsterdam, New York, Oxford
36. Liechti M.E., Geyer M.A., Hell D., Vollenweider F.X. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology. 24:2001;240-252
37. Litman R.E., Pickar D. Noradrenergic systems: a target for augmenting pharmacotherapy. Breier A. The New Pharmacotherapy of Schizophrenia. 1996;133-152 American Psychiatric Press, Washington, DC
38. Mansbach R.S., Geyer M.A. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology. 2:1989;299-308
39. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514
40. Martinez D.L., Geyer M.A. Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine. Neuropsychopharmacology. 16:1997;246-255
41. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. British Journal of Medical Psychology. 34:1961;103-116
42. McGuffin P., Owen M.J., Farmer A.E. Genetic basis of schizophrenia. Lancet. 346:1995;678-682
43. Oranje B., Gispen-de Wied C.C., Verbaten M.N., Kahn R.S. Modulating sensory gating in healthy volunteers. The effects of ketamine and haloperidol. Biological Psychiatry. 52:2002a;887-895
44. Oranje, B., Geyer, M.A., Kenemans, J.L., Verbaten, M.N. 2002b. Prepulse inhibition and P50 suppression: commonalities and dissociations. Submitted
45. Padich R.A., McCloskey T.C., Kehne J.H. 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology. 124:1996;107-116
46. Perry W., Minassian A., Feifel D., Braff D.L. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biological Psychiatry. 50:2001;418-424
47. Phillips M.A., Langley R.W., Bradshaw C.M., Szabadi E. The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. Journal of Psychopharmacology. 14:2000;40-45
48. Rigdon G.C., Weatherspoon J.K. 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. Journal of Pharmacology and Experimental Therapeutics. 263:1992;486-493
49. Sipes T.E., Geyer M.A. DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum. Brain Research. 761:1997;97-104
50. Svensson L., Ahlenius S. Enhancement by the putative 5-HT receptor agonist 8-OH-2-(di-n-propylamino)tetralin of the acoustic startle response in the rat. Psychopharmacology. 79:1983;104-107
51. Swerdlow N.R., Bakshi V., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. Journal of Pharmacology and Experimental Therapeutics. 279:1996;1290-1299
52. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology. 156:2001;194-215
53. Tanda G., Pontieri F.E., Frau R., Di Chiara G. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. European Journal of Neuroscience. 9:1997;2077-2085
54. Venables P.H. Input dysfunction in schizophrenia. Maher B.A. Progress in Experimental Personality Research. 1964;1-47 Academic Press, New York, London
55. Yamamoto B.K., Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. Journal of Neurochemistry. 71:1998;274-280
56. Zavitsanou K., Cranney J., Richardson R. Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat. Pharmacology, Biochemistry and Behavior. 63:1999;55-61